Items where Research Centre is "Leishmaniasis Group"

  • Research Centres (23573)
  • Leishmaniasis Group (289)
    Number of items: 10.
    Article
  • Estimating the costs of implementing the rotavirus vaccine in the national immunisation programme: the case of Malawi. (2013) Madsen, Lizell B; Ustrup, Marte; Hansen, Kristian S; Nyasulu, Peter S; Bygbjerg, Ib C; Konradsen, Flemming
  • Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs. (2013) Munday, Jane C; Eze, Anthonius A; Baker, Nicola; Glover, Lucy; Clucas, Caroline; Aguinaga Andrés, David; Natto, Manal J; Teka, Ibrahim A; McDonald, Jennifer; Lee, Rebecca S; Graf, Fabrice E; Ludin, Philipp; Burchmore, Richard JS; Turner, C Michael R; Tait, Andy; MacLeod, Annette; Mäser, Pascal; Barrett, Michael P; Horn, David; De Koning, Harry P
  • Clinical epidemiology, diagnosis and treatment of visceral leishmaniasis in the Pokot endemic area of Uganda and Kenya. (2013) Mueller, Yolanda K; Kolaczinski, Jan H; Koech, Timothy; Lokwang, Peter; Riongoita, Mark; Velilla, Elena; Brooker, Simon J; Chappuis, François
  • Arginase activity - a marker of disease status in patients with visceral leishmaniasis in ethiopia. (2013) Abebe, Tamrat; Takele, Yegnasew; Weldegebreal, Teklu; Cloke, Tom; Closs, Ellen; Corset, Camille; Hailu, Asrat; Hailu, Workagegnehu; Sisay, Yifru; Corware, Karina; Corset, Margaux; Modolell, Manuel; Munder, Markus; Tacchini-Cottier, Fabienne; Müller, Ingrid; Kropf, Pascale
  • Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by X-ray crystallography. (2013) Baiocco, Paola; Poce, Giovanna; Alfonso, Salvatore; Cocozza, Martina; Porretta, Giulio Cesare; Colotti, Gianni; Biava, Mariangela; Moraca, Francesca; Botta, Maurizio; Yardley, Vanessa; Fiorillo, Annarita; Lantella, Antonella; Malatesta, Francesco; Ilari, Andrea
  • Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis. (2013) LeishGEN Consortium; Wellcome Trust Case Control Consortium 2; Fakiola, Michaela; Strange, Amy; Cordell, Heather J; Miller, E Nancy; Pirinen, Matti; Su, Zhan; Mishra, Anshuman; Mehrotra, Sanjana; Monteiro, Gloria R; Band, Gavin; Bellenguez, Céline; Dronov, Serge; Edkins, Sarah; Freeman, Colin; Giannoulatou, Eleni; Gray, Emma; Hunt, Sarah E; Lacerda, Henio G; Langford, Cordelia; Pearson, Richard; Pontes, Núbia N; Rai, Madhukar; Singh, Shri P; Smith, Linda; Sousa, Olivia; Vukcevic, Damjan; Bramon, Elvira; Brown, Matthew A; Casas, Juan P; Corvin, Aiden; Duncanson, Audrey; Jankowski, Janusz; Markus, Hugh S; Mathew, Christopher G; Palmer, Colin NA; Plomin, Robert; Rautanen, Anna; Sawcer, Stephen J; Trembath, Richard C; Viswanathan, Ananth C; Wood, Nicholas W; Wilson, Mary E; Deloukas, Panos; Peltonen, Leena; Christiansen, Frank; Witt, Campbell; Jeronimo, Selma MB; Sundar, Shyam; Spencer, Chris CA; Blackwell, Jenefer M; Donnelly, Peter
  • Noncovalent complexation of amphotericin-B with Poly(α-glutamic acid). (2013) Mohamed-Ahmed, Abeer HA; Les, Karolina A; Seifert, Karin; Croft, Simon L; Brocchini, Stephen
  • An essential type I nitroreductase from Leishmania major can be used to activate leishmanicidal prodrugs. (2013) Voak, Andrew A; Gobalakrishnapillai, Vithurshaa; Seifert, Karin; Balczo, Edina; Hu, Longqin; Hall, Belinda S; Wilkinson, Shane R
  • Book Section
  • Anti-infectives. (2013) Ahmed, A; Ginn, C; Croft, SL; Brocchini, S
  • The relevance of susceptibility tests, breakpoints and markers. (2013) Maes, L; Cos, P; Croft, SL